US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 19:34:07 Source：Global Grid news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Baby Reindeer's real
- Next：The fightback begins: Boss of London's Queen Mary University tells pro
Related articles
- Insider Q&A: CIA's chief technologist's cautious embrace of generative AI
- China and Russia hold first joint navy patrol in Pacific
- Inside the Cold War
- Could this be an answer to YOUR blemish
- Why US Catholics are planning pilgrimages in communities across the nation
- Vanessa Hudgens displays her baby bump in a tight
- I'm from Texas and live in the UK, these are all the weird things I've found about British people
- Fin Affleck's close friendship with JLo's child Emme Maribel Munniz, 16
- Kevin Pillar gets 1,000th career hit in Angels' win at Texas
- Callaghan Innovation wants to cut staff, focus on money
- Jon Wysocki dead at 53: Staind drummer passes away
- Woman's rare disease causes 20
- NHS waiting lists fall for fifth month in a row as Rishi Sunak says 'our plan is working'
- I was uninvited to my best friend's wedding
- Yvette Fielding says her Most Haunted co
- How Los Angeles police are fighting back against organized retail theft
- Hong Kong's leading bookstores decline to stock new book by last governor Chris Patten
- What is Havana syndrome? Symptoms explained after bombshell 60 Minutes episode
- Company wins court ruling to continue development of Michigan factory serving EV industry
- McDonald's praised for innovative ad that smells exactly like classic item on their menu
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Global Grid news portal sitemap